ificantly different for CEA (4.4%) or for CAS (2.1%),
and noninferiority of CAS was not demonstrated by statistical methodology.222
In 2004, the Stenting and Angioplasty with Protection
in Patients at High Risk for Endarterectomy (SAPPHIRE)
trial, which included “high-risk” patients, 70% of whom
were asymptomatic, demonstrated that the results of stenting with cerebral